{
    "Clinical Information": [],
    "Patent Information": [],
    "Sequence Information": {
        "DRAMP ID": "DRAMP00033",
        "Peptide Name": "Lantibiotic epilancin 15X (Bacteriocin)",
        "Source": "Staphylococcus epidermidis 15X154 (Gram-positive bacteria)",
        "Family": "Belongs to the type A lantibiotic family (Class I bacteriocin)",
        "Gene": "Not found",
        "Sequence": "ASIVKTTIKASKKLCRGFTLTCGCHFTGKK",
        "Sequence Length": "30",
        "UniProt Entry": [
            "http://www.uniprot.org/uniprot/P86047"
        ],
        "Protein Existence": "Protein level",
        "Biological Activity": [
            "Antimicrobial, Antibacterial, Anti-Gram+"
        ],
        "Target Organism": "Gram-positive bacteria:resistant bacterial strains Staphylococcus aureus (MRSA) and VRE.",
        "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
        "Cytotoxicity": "Not included yet",
        "Binding Target": "Not found",
        "Linear/Cyclic": "Not included yet",
        "N-terminal Modification": "Not included yet",
        "C-terminal Modification": "Not included yet",
        "Nonterminal Modifications and Unusual Amino Acids": "Not included yet",
        "Stereochemistry": "Not included yet",
        "Structure": "Non helix or strand structure",
        "Structure Description": "The molecule contains ten post-translationally modified amino acids, three lanthionine ring structures and a hydroxy-propionyl N-terminal moiety.",
        "Helical Wheel Diagram": "",
        "PDB ID": "1W9Nresolved  by NMR.",
        "Predicted Structure": "There is no predicted structure for DRAMP00033.",
        "Formula": "C142H243N41O38S3",
        "Absent Amino Acids": "DEMNPQWY",
        "Common Amino Acids": "K",
        "Mass": "3228.92",
        "PI": "10.07",
        "Basic Residues": "8",
        "Acidic Residues": "0",
        "Hydrophobic Residues": "9",
        "Net Charge": "+8",
        "Boman Index": "-32.57",
        "Hydrophobicity": "0.003",
        "Aliphatic Index": "68.33",
        "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
        "Extinction Coefficient Cystines": "125",
        "Absorbance 280nm": "4.31",
        "Polar Residues": "13",
        "Function": "Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria",
        "PTM": "There are one Lactic acid (S1), one 2,3-didehydroalanine (S3) and three 2,3-dehydrobutyrines (T7; T8; T28); also one Lanthionine (S12-C16) and two Beta-methyllanthionines (T20-C23; T22-C25).",
        "Literature": [
            {
                "Title": "Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.",
                "Pubmed ID": "15792796",
                "Reference": "FEBS Lett. 2005 Mar 28;579(9)1917-1922.",
                "Author": "Ekkelenkamp MB, Hanssen M, Danny Hsu ST, de Jong A, Milatovic D, Verhoef J, van Nuland NA.",
                "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15792796"
            }
        ],
        "3D_Structures": [
            {
                "pdb_id": "1W9N",
                "3d_structure_url": "https://www.rcsb.org/structure/1W9N"
            }
        ]
    }
}